Global Dialysis Market By Dialysis Type (Hemodialysis and Peritoneal Dialysis), By Product and Services (Equipment, Consumables, Dialysis Drugs, and Services), By End-User (Dialysis Centers and Hospitals, Home Care, and Other End-Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Jan 2024
- Report ID: 101342
- Number of Pages: 325
The Global Dialysis Market size is expected to be worth around USD 198.1 Billion by 2033 from USD 116.0 Billion in 2023, growing at a CAGR of 5.5% during the forecast period from 2024 to 2033.
Dialysis is a treatment for chronic renal failure that is typically required to remove waste products from the blood, such as creatinine and urea, due to abnormal kidney function. The treatment of end-stage renal disease (ESRD) and kidney transplants rely heavily on this procedure. There are two types of dialysis: hemodialysis and peritoneal dialysis. Waste products like urea are extracted extracorporeally from the patient’s blood during hemodialysis. The abdomen’s peritoneum is utilized for peritoneal dialysis.
The rise in end-stage renal disease (ESRD) patients, an increase in funding for the creation of new products, and an increase in the number of diabetic and hypertensive patients are all responsible for the expansion of the market. Additionally, dialysis is favored over kidney transplantation, which is anticipated to boost the dialysis market’s expansion. In addition, the market expansion is anticipated to be fueled by the rising geriatric population, rising healthcare expenditures, and rising disposable income.
- Dialysis Market size is expected to be worth around USD 198.1 Billion by 2033 from USD 116.0 Billion in 2023
- The market CAGR of 5.5% during the forecast period from 2024 to 2033.
- The hemodialysis segment dominates the market with a share of over 67.3%.
- The services segment held 41.3% largest market share in 2023, primarily due to the rise in service providers’ emphasis on providing high-quality care to patients.
- Dialysis centers & hospitals dominated 57.8% market share in 2023, due to favorable reimbursement offered by renal facilities and hospitals for renal treatments.
- North America is anticipated to hold 31.6% market share and USD 36.6 Bn market revenue.
- Key drivers of the dialysis market include the increasing number of chronic kidney diseases, increased accessibility to hemodialysis facilities, and growing preference for home-based dialysis products.
- Key restraints of the dialysis market include the growing number of patients choosing kidney transplantation and complications associated with dialysis.
- Emerging markets in Asia Pacific & RoW present significant growth opportunities for dialysis market players.
Dialysis Type Analysis
In 2023, the hemodialysis segment dominated the market with the largest revenue share
Based on type, the market for dialysis is divided into hemodialysis and peritoneal dialysis. Hemodialysis is further subdivided into conventional hemodialysis nocturnal hemodialysis short-term hemodialysis. Continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) are further subcategories of peritoneal dialysis.
In 2023, the market share of the hemodialysis segment was approximately 67.3% compared to peritoneal. The high segmental growth is because hemodialysis helps keep salt, calcium, and potassium levels balanced, lowering blood pressure. Additionally, the arteriovenous (AV) fistula is the most common vascular access for hemodialysis patients. In addition, it takes less time than peritoneal dialysis. However, peritoneal dialysis is anticipated to be the fastest-growing segment over the forecast period due to the efficient removal of toxic substances and rising demand for home care among dialysis patients.
Product & Services Analysis
The services segment held the largest market share in 2023
Based on products & services, the global dialysis market is segmented into equipment, consumables, dialysis drugs, and services. In 2023, services accounted for the 41.3% market share, primarily as a result of the rise in service providers’ emphasis on providing high-quality care to patients and the development of well-equipped renal care facilities for both chronic and acute care. Additionally, the demand for services is rising as a result of service providers’ improved business models, which are profit-oriented and patient-centered. Due to an increase in the number of local and regional players in this market to meet the rising demand for advanced products and consumables, the products segment is anticipated to experience healthy growth in the coming years.
The dialysis drugs segment is anticipated to grow more in the coming years. This is largely due to the majority of dialysis patients having anemia. Thus the use of drugs like erythropoietin, iron, active vitamin D, phosphorus binders, B-complex vitamin & folic acid, topical creams & antihistamines, and vitamin E is increasing rapidly.
In 2023, dialysis centers & hospitals dominated the market
Based on end-users, the market for dialysis is classified into dialysis centers & hospitals, home care, and other end-users. Due to favorable reimbursement offered by renal facilities and hospitals for renal treatments, an expanding patient population with CKD and ESRD, and rising population healthcare spending, dialysis centers & hospitals held 57.8% largest value share of the market in 2023.
Key Market Segments
By Dialysis Type
- Peritoneal Dialysis
By Product & Services
- Dialysis Drugs
- Dialysis Centers & Hospitals
- Home Care
- Other End-Users
The increasing number of chronic kidney diseases is expected to increase the dialysis demand
In terms of healthcare costs and services, ESRD and CKD represent one of the highest burdens overall. One of the main drivers of this market’s expansion is the rising prevalence of renal failure and other chronic kidney diseases. ESRD occurs when one or both kidneys permanently cease to function properly, necessitating long-term renal infusion therapy or a kidney transplant. As a result, the rising incidence of end-stage renal disease (ESRD) is contributing to an increase in the global cost of kidney diseases and is one of the primary drivers of the services’ growing revenue.
In addition, it is anticipated that the market growth will be boosted by regulatory authorities’ approval of new products and consumables, public authorities’ participation in the prevention and control of renal diseases, and the collaborative efforts of various organizations to provide such effective renal services in niche areas of developing regions.
Increased Accessibility to Hemodialysis Facilities to Fuel Market Expansion
As chronic kidney disease (CKD) has skyrocketed, the need for effective renal facilities with shorter waiting times is growing. The number of renal care facilities has increased as a result of the availability of highly skilled nephrologists in developed countries. In addition, investors are concentrating more on expanding renal treatment centers in nations like China, India, Mexico, and others in order to meet the rising demand for renal care in emerging economies. The market’s revenue is expected to rise as a result of this in the coming years. The number of visits to these facilities is rising due to the affordable care provided in these nations.
The increasing number of patients choosing kidney transplantation limits the market growth
One alternative treatment option for ESRD and stage III CKD patients is kidney transplantation, in which a healthy kidney is taken from a donor and transplanted into the patient. During the forecast period, the market growth is anticipated to be influenced by the improved treatment outcomes associated with kidney transplants and the procedure’s affordability due to favorable reimbursement policies. Because of the procedure’s long-term benefits, patients with ESRD prefer kidney transplantation to renal infusion. In addition, the coronavirus pandemic in India has been linked to an increase in the cost of renal therapy, according to published articles and journals. This could hinder the expansion of the market.
Complications and risks associated with dialysis
Vascular access-related complications like bleeding and cardiac diseases (arrhythmic mechanisms or sudden cardiac arrest) are examples of complications. Low blood pressure, infection, nausea, hernia, hepatitis, and anemia account for the majority of dialysis patients’ deaths. Peritonitis is a common complication of peritoneal dialysis that can be caused by infections caused by catheters or by pathogenic skin bacteria contaminating the dialysate or tubing.
Emerging Markets in Asia Pacific & RoW
Major Players in the dialysis market are anticipated to create significant growth opportunities in emerging markets like India, China, Mexico, and Brazil. The highest rates of treated ESRD are found in Taiwan and Malaysia. In order to take advantage of the significant growth opportunities in emerging nations, companies are increasingly focusing on strategic development agreements, partnerships, geographical expansions, and acquisitions to increase their market share and reach a large number of customers. The development of home/nocturnal dialysis, the expansion of dialysis centers, and government funding for ESRD treatment are also contributing to the growth of dialysis procedures in developing nations.
Rising incidence of CKD, increase in new product launches and healthcare expenditures, and growing preference for home-based dialysis products
The global dialysis market is expanding due to the rising incidence of chronic kidney diseases, the high demand for advanced dialysis solutions, and the rise in new home dialysis product launches.
The market’s expansion is also aided by several other significant factors, including the ongoing creation of new products and rising healthcare expenditures. In addition, the global dialysis market’s important trend of favoring peritoneal dialysis and increasing the use of home-based dialysis products is anticipated to bring numerous opportunities in the near future.
North America dominated the market for dialysis, with the largest market share
Based on region, the market for dialysis is classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold 31.6% market share and USD 36.6 Bn market revenue. Market expansion is anticipated to be fueled by the high prevalence of CKD and ESRD in the United States and Canada and the higher treatment rates there. Due to the rising incidence of coronavirus infections and their associated renal failures, there is also anticipated to be an increase in demand for services and products in the United States. With moderate long-term growth, Europe is anticipated to be this market’s second-largest region. The growing number of elderly people with renal conditions is primarily to blame for the region’s rapid growth.
In addition, Asia-Pacific is anticipated to experience relatively significant growth in this market. Market expansion is anticipated to be aided by public-sector funding to improve access to renal care over the forecast period. The market for services and goods is expanding in Brazil as a result of the rising prevalence of chronic kidney disease among the elderly population. Due to the delayed diagnosis of chronic CKD and ESRD, the Middle East and Africa region is expected to show slow to moderate growth over the forecast period. However, the primary factors that are anticipated to propel revenue from this region during the forecast period are the region’s rapid urbanization and growing awareness of the severity of renal diseases.
- North America
- The US
- Western Europe
- The UK
- Rest of Western Europe
- Eastern Europe
- The Czech Republic
- Rest of Eastern Europe
- South Korea
- Australia & New Zealand
- Rest of APAC
- Latin America
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
- Rest of MEA
Key Players Analysis
The major players in the market are concentrating on new product launches, growth plans, and technological advancements. Over the forecast period, market growth is anticipated to be boosted by such strategies of key players.
Fresenius Medical Care AG & Co. KGaA is one of the largest providers of renal disease patients with products and services. It provides goods and services across the entire value chain from a single source. Dialysis and Non-dialysis products are the two main divisions that comprise its healthcare products division. The dialysis products segment provides products for hemodialysis and peritoneal dialysis. Through a large number of production sites, the company designs develops, and sells dialysis products to more than 150 nations. Listed below are some of the prominent players in the global dialysis market.
Market Key Players
- B. Braun
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Corporation
- Becton, Dickinson, and Company
- DaVita Inc.
- Medtronic plc
- Nipro Corporation
- NIKKISO CO., LTD.
- Satellite Healthcare Inc.
- Toray Industries, Inc.
- Other Key Players
- B. Braun: Acquired Nephrocare GmbH, expanding their peritoneal dialysis product portfolio.
- Baxter International Inc.: Announced collaboration with Siemens Healthineers on AI-powered dialysis data management.
- Fresenius Medical Care AG & Co. KGaA: Invested in digital health solutions for remote patient monitoring in dialysis.
- Asahi Kasei Corporation: Formed a partnership with Nipro Corporation for joint research and development in dialysis technologies.
- Becton, Dickinson and Company (BD): Collaborating with healthcare providers on improving efficiency and safety in dialysis procedures.
- DaVita Inc.: Launched new care models using telehealth and remote monitoring for home dialysis patients.
Report Features Description Market Value (2023) USD 116.0 Billion Forecast Revenue (2033) USD 198.1 Billion CAGR (2024-2033) 5.5% Base Year for Estimation 2023 Historic Period 2018-2022 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered By Dialysis Type – Hemodialysis and Peritoneal Dialysis; By Product & Services – Equipment, Consumables, Dialysis Drugs, and Services; By End-User – Dialysis Centers & Hospitals, Home Care, and Other End-Users Regional Analysis North America-US, Canada, Mexico;Europe-Germany, UK, France, Italy, Russia, Spain, Rest of Europe;APAC-China, Japan, South Korea, India, Rest of Asia-Pacific;South America-Brazil, Argentina, Rest of South America;MEA-GCC, South Africa, Israel, Rest of MEA Competitive Landscape B. Braun, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Becton, Dickinson and Company, DaVita Inc., Medtronic plc, Nipro Corporation, NIKKISO CO., LTD., Satellite Healthcare Inc., Toray Industries, Inc., Other Key Players Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
Frequently Asked Questions (FAQ)What does the Dialysis Market encompass?
The Dialysis Market includes the medical devices, equipment, and services used for treating patients with kidney failure by artificially filtering waste and excess fluids from their blood.How big is the Dialysis Market?
The global Dialysis Market size was estimated at USD 116.0 Billion in 2023 and is expected to reach USD 198.1 Billion in 2033.What is the Dialysis Market growth?
The global Dialysis Market is expected to grow at a compound annual growth rate of 5.5%. From 2024 To 2033Who are the key companies/players in the Dialysis Market?
Some of the key players in the Dialysis Markets are B. Braun, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Becton, Dickinson and Company, DaVita Inc., Medtronic plc, Nipro Corporation, NIKKISO CO., LTD., Satellite Healthcare Inc., Toray Industries, Inc., Other Key Players.What are the key types of dialysis treatments available?
The two primary types of dialysis are hemodialysis and peritoneal dialysis. Hemodialysis uses a machine to filter blood externally, while peritoneal dialysis uses the patient's peritoneal membrane to perform filtration.Which regions exhibit significant market growth?
North America, particularly the United States, and Europe have a prominent presence in the Dialysis Market. Asia-Pacific is also witnessing substantial growth due to the increasing prevalence of kidney diseases.How does the market address patient safety and treatment efficiency?
The market focuses on improving patient safety through better dialysis machine design, infection control measures, and remote monitoring of patients. Efficiency is enhanced through automated systems and improved dialysate solutions.What challenges does the Dialysis Market face?
Challenges include the high cost of treatment, limited reimbursement in some regions, and the need for better access to dialysis services in developing countries.
| Single User
USD / per unit
| Multi User
USD / per unit
| Corporate User
USD / per unit
|Report Library Access
|Data Set (Excel)
|Company Profile Library Access
|up to 10 hrs work
|up to 30 hrs work
|up to 20 hrs
|up to 40 hrs
|up to 50 hrs
|Up to 20% off on next purchase
|Up to 25% off on next purchase
|Up to 30% off on next purchase
|Buy Now ($ 3,499)
|Buy Now ($ 4,299)
|Buy Now ($ 4,999)